VR
Vishal Ratilal Patel
About Vishal Ratilal Patel
Data last updated:
Vishal Ratilal Patel is a Director at Sunflower Women's Endo Infertility And Hospital Private Limited (since 2017), Partner at Curequest Lifescience Llp (since 2025) and Director at Acute Research Private Limited (since 2017), and holds 2 more current directorships. The companies operate in Healthcare, Pharma and Paper. The 3 current companies with reported revenue have a combined latest revenue of ₹69.43 Cr; the largest is Sunflower Women's Endo Infertility And Hospital Private Limited at ₹49.42 Cr (FY 2025). Earlier, Vishal Ratilal Patel was a Director at Noacheean Engineers And Consultants Private Limited (2018–2022) and Additional Director at Cureill Pharma Private Limited (2014–2017).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sunflower Women's Endo Infertility And Hospital Private Limited U85110GJ2008PTC055546 | Director | 14 Jun 2017 | 2008 | ₹49.42 Cr (FY 2025) | Active |
 Curequest Lifescience Llp AAQ-3406 | Partner | 30 Jan 2025 | 2019 | ₹11.03 Cr (FY 2024) | Active |
 Acute Research Private Limited U73100GJ2017PTC099342 | Director | 04 Oct 2017 | 2017 | ₹8.99 Cr (FY 2024) | Active |
 Adaptyx Private Limited U58200GJ2025PTC168185 | Director | 25 Sep 2025 | 2025 | Active | |
| Cure Molecules Private Limited U21000GJ2025PTC159538 | Director | 27 Feb 2025 | 2025 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Noacheean Engineers And Consultants Private Limited U45309RJ2018PTC060314 | Director | 23 Feb 2018 | 2018 | ₹2.77 Cr (FY 2021) | Active |
 Cureill Pharma Private Limited U24100GJ2014PTC080448 | Additional Director | 28 Nov 2014 | 2014 | ₹5.26 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Vishal Ratilal Patel
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ratilal Gopaldas Patel | 00373555 | Sunflower Women's Endo Infertility And Hospital Private Limited | Director |
| Nimish Vajubhai Thakrar | 08543629 | Curequest Lifescience Llp | Designated Partner |
| Ritwik Majumder | 03637490 | Curequest Lifescience Llp | Designated Partner |
| Daxaben Ratibhai Patel | 01538787 | Acute Research Private Limited | Director |
| Het Dharmendra Thakkar | 11316766 | Adaptyx Private Limited | Director |
| Pujan Paragkumar Patel | 11316765 | Adaptyx Private Limited | Director |
| Jigar Bharatkumar Saija | 10974372 | Cure Molecules Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vishal Ratilal Patel
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vishal Ratilal Patel
Vishal Ratilal Patel currently holds 5 directorships: Sunflower Women's Endo Infertility And Hospital Private Limited (Director, since 14 Jun 2017, revenue ₹49.42 Cr (FY 2025)); Curequest Lifescience Llp (Partner, since 30 Jan 2025, revenue ₹11.03 Cr (FY 2024)); Acute Research Private Limited (Director, since 04 Oct 2017, revenue ₹8.99 Cr (FY 2024)); Adaptyx Private Limited (Director, since 25 Sep 2025); Cure Molecules Private Limited (Director, since 27 Feb 2025).
Vishal Ratilal Patel was first appointed on 28 Nov 2014 as Additional Director at Cureill Pharma Private Limited. The most recent appointment on record is 25 Sep 2025 at Adaptyx Private Limited.
The 3 current companies of Vishal Ratilal Patel that report revenue have a combined latest revenue of ₹69.43 Cr: Sunflower Women's Endo Infertility And Hospital Private Limited ₹49.42 Cr (FY 2025); Curequest Lifescience Llp ₹11.03 Cr (FY 2024); Acute Research Private Limited ₹8.99 Cr (FY 2024).
Vishal Ratilal Patel held 2 earlier board appointments: Noacheean Engineers And Consultants Private Limited (Director, 23 Feb 2018 to 30 Sep 2022); Cureill Pharma Private Limited (Additional Director, 28 Nov 2014 to 14 Nov 2017).
The current boards of Vishal Ratilal Patel's companies include Ratilal Gopaldas Patel (Sunflower Women's Endo Infertility And Hospital Private Limited), Nimish Vajubhai Thakrar (Curequest Lifescience Llp), Ritwik Majumder (Curequest Lifescience Llp), Daxaben Ratibhai Patel (Acute Research Private Limited), Het Dharmendra Thakkar (Adaptyx Private Limited), Pujan Paragkumar Patel (Adaptyx Private Limited), among others.